EVOK - Evoke Pharma Inc
11
0.040 0.364%
Share volume: 47,105
Last Updated: 12-16-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$10.96
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-07-2024 | 03-13-2025 | 05-13-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 12.454 M | 12.136 M | 14.154 M | 17.519 M | 16.376 M | 16.060 M | 15.649 M | |
| Current Assets | 12.454 M | 12.136 M | 14.038 M | 17.238 M | 16.231 M | 15.931 M | 15.536 M | |
| Inventories | 588.776 K | 544.765 K | 493.408 K | 445.081 K | 532.145 K | 641.872 K | 599.908 K | |
| Other Current Assets | 6.312 K | 27.675 K | 36.421 K | 43.898 K | 39.240 K | 36.119 K | 33.708 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 9.703 M | 9.178 M | 11.339 M | 13.597 M | 12.624 M | 12.059 M | 11.576 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 0.000 | 0.000 | 115.488 K | 281.110 K | 145.070 K | 129.250 K | 113.026 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 12.454 M | 12.136 M | 14.154 M | 17.519 M | 16.376 M | 16.060 M | 15.649 M | |
| Total liabilities | 8.957 M | 9.471 M | 9.766 M | 10.481 M | 10.535 M | 11.686 M | 12.287 M | |
| Total current liabilities | 8.957 M | 9.471 M | 9.766 M | 10.380 M | 10.452 M | 11.621 M | 12.241 M | |
| Accounts Payable | 1.954 M | 2.184 M | 2.188 M | 2.341 M | 2.781 M | 3.588 M | 3.916 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 100.958 K | 83.217 K | 65.028 K | 46.381 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 100.958 K | 83.217 K | 65.028 K | 46.381 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.497 M | 2.665 M | 4.387 M | 7.038 M | 5.841 M | 4.374 M | 3.362 M | |
| Common stock | 128.516 M | 128.951 M | 131.986 M | 135.830 M | 135.939 M | 136.043 M | 136.187 M | |
| Retained earnings | -125.019 M | -126.286 M | -127.599 M | -128.792 M | -130.098 M | -131.669 M | -132.825 M |